Efficacy and safety of low ‐dose prophylaxis of highly purified plasma‐derived factor VIII concentrate produced by the National Blood Centre, Thai Red Cross Society

Haemophilia, EarlyView.

Source: Haemophilia - August 17, 2018 Category: Hematology Authors: Ampaiwan Chuansumrit , Darintr Sosothikul , Rungrote Natesirinilkul , Yujinda Lektrakul , Ubonwon Charoonruangrit , , Kanhati Chiengthon , Kwannut Srikala , Pakawan Wongwerawattanakoon , Praguywan Kadegasem , Pi Source Type: research